BackSenti Biosciences Overview

Senti Biosciences Current Cash

Track Senti Biosciences's current cash ($6.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.46M
↓ 70.05% YoYΔ $-15.11M vs prior year quarter

Peer trimmed avg / median

Loading

Senti Biosciences Current Cash History

Loading

Senti Biosciences vs. peers: Current Cash Comparison

Loading

Senti Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Senti Biosciences (SNTI) FAQ

The latest current cash for SNTI is $6.5M as of June 2026. That compares with $22M in the prior-year period — down 70.0% year over year. Investors often review this figure alongside Senti Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SNTI's current cash moved from $22M to $6.5M — a 70.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Senti Biosciences's operating scale or balance-sheet position.

A current cash figure of $6.5M for SNTI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SNTI's current cash ($6.5M), review year-over-year change from $22M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.